Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.

@article{Franklin2011CognitiveBT,
  title={Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.},
  author={Martin E. Franklin and Jeffrey J. Sapyta and Jennifer B Freeman and Muniya Khanna and Scott Compton and Daniel Almirall and Phoebe Moore and Molly L. Choate-Summers and Abbe Marrs Garcia and Aubrey L Edson and Edna B Foa and John S. March},
  journal={JAMA},
  year={2011},
  volume={306 11},
  pages={1224-32}
}
CONTEXT The extant literature on the treatment of pediatric obsessive-compulsive disorder (OCD) indicates that partial response to serotonin reuptake inhibitors (SRIs) is the norm and that augmentation with short-term OCD-specific cognitive behavior therapy (CBT) may provide additional benefit. OBJECTIVE To examine the effects of augmenting SRIs with CBT or a brief form of CBT, instructions in CBT delivered in the context of medication management. DESIGN, SETTING, AND PARTICIPANTS A 12-week… CONTINUE READING